The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
The U.S. Food and Drug Administration May 23 authorized marketing of a diagnostic test for detecting Zika virus antibodies in human blood.
Headline
The Joint Commission yesterday recommended that health care organizations review cleaning and disinfection instructions for tonometers and other ophthalmology…
Headline
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company…
Blog
America’s hospitals and health systems are dedicated to doing everything possible for patients, particularly when they need emergency care and as a place for…
Headline
Hospitals, health systems and other health care organizations can sign up this week to host an intern for this year's Institute for Diversity and Health Equity…
Headline
The Centers for Disease Control and the National Tuberculosis Controllers Association this week released updated recommendations for TB screening and testing…